Rutgers University’s saliva-based COVID-19 test gets FDA approval
New Jersey-based Rutgers University’s RUCDR Infinite Biologics and its collaborators have been granted emergency use authorization (EUA status) for their saliva-based COVID-19 test by the US Food and Drug Administration (FDA). The new COVID-19 test uses saliva as the main test biomaterial for the SARS-CoV-2 coronavirus. The EUA status permits the immediate use of saliva […]